kiss1-protein--human and Hypothyroidism

kiss1-protein--human has been researched along with Hypothyroidism* in 5 studies

Other Studies

5 other study(ies) available for kiss1-protein--human and Hypothyroidism

ArticleYear
Kisspeptin treatment reverses high prolactin levels and improves gonadal function in hypothyroid male rats.
    Scientific reports, 2023, 10-05, Volume: 13, Issue:1

    We evaluated whether the administration of kisspeptin-10 (Kp10) is capable of restoring gonadal function in hypothyroid male rats. Hypothyroidism was induced with 6-propyl-2-thiouracil (PTU) for three months. In the last month, half of the hypothyroid animals were treated with Kp10. Hypothyroidism reduced testicular and sex gland mass, decreased the proliferation of the seminiferous epithelium, and compromised sperm morphology, motility, and vigor. A decrease in plasma LH and testosterone levels and an increase in prolactin secretion were observed in the hypothyroid rats. Hypothyroidism reduced Kiss1 and Kiss1r protein and gene expression and Star and Cyp11a1 mRNA levels in the testis. Furthermore, it reduced Lhb, Prl, and Drd2 and increased Tshb and Gnrhr expression in the pituitary. In the hypothalamus, hypothyroidism increased Pdyn and Kiss1r while reducing Gnrh1. Kp10 treatment in hypothyroid rats restored testicular and seminal vesicle morphology, improved sperm morphology and motility, reversed high prolactin levels, and increased LH and testosterone levels. In addition, Kp10 increased testicular expression of Kiss1, Kiss1r, Fshr, and Nr5a1 and pituitary Kiss1 expression. Our findings describe the inhibitory effects of hypothyroidism on the male gonadal axis and sperm quality and demonstrate that Kp10 treatment reverses high prolactin levels and improves gonadal function and sperm quality in hypothyroid rats.

    Topics: Animals; Hypothyroidism; Kisspeptins; Luteinizing Hormone; Male; Prolactin; Rats; Receptors, Kisspeptin-1; Semen; Testis; Testosterone

2023
Maternal hypothyroidism reduces the expression of the kisspeptin/Kiss1r system in the maternal-fetal interface of rats.
    Reproductive biology, 2022, Volume: 22, Issue:2

    Alterations of circulating and placental levels of kisspeptin have been associated with gestational diseases. However, there are still no studies on the placental and decidual expression of Kiss1 and its receptor Kiss1r in maternal hypothyroidism, which is the aim of this work. We demonstrate that the fetoplacental restriction caused by hypothyroidism in rats is associated with a reduction in the Kiss1r expression and reduced Kiss1 and Kiss1r mRNA levels in the decidua and/or placenta. This demonstrate that fetoplacental restriction in hypothyroid rats is linked with a suppression of the kisspeptin/Kiss1r system at the maternal-fetal interface.

    Topics: Animals; Female; Hypothyroidism; Kisspeptins; Placenta; Pregnancy; Rats; Receptors, G-Protein-Coupled; Receptors, Kisspeptin-1

2022
Kisspeptin Treatment Restores Ovarian Function in Rats with Hypothyroidism.
    Thyroid : official journal of the American Thyroid Association, 2022, Volume: 32, Issue:12

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Cholesterol Side-Chain Cleavage Enzyme; Female; Hyperprolactinemia; Hypothyroidism; Kisspeptins; Luteinizing Hormone; Prolactin; Rats; Rats, Wistar; RNA, Messenger

2022
Kisspeptin expression is decreased in the arcuate nucleus of hypothyroid female rats with irregular estrus cycles.
    Neuroscience research, 2017, Volume: 117

    Insufficiency of thyroid hormones inhibits gonadotropin release and results in dysregulation of reproductive function, although the precise mechanism of this disrupted gonadotropin secretion remains unclear. Kisspeptin is a neuropeptide that strongly stimulates gonadotropin secretion and plays an important role in reproductive function. To examine the involvement of kisspeptin in the dysregulation of gonadotropin secretion in hypothyroidism, we investigated Kiss1 mRNA expression and kisspeptin immunoreactivity in the hypothalamus of female rats treated with propylthiouracil (PTU). In the PTU-treated rats, serum thyroxine (T4) was significantly decreased, whereas thyroid stimulating hormone (TSH) levels were significantly increased. In addition, irregular estrus cycles were observed in PTU-treated rats. In situ hybridization and immunohistochemistry revealed significant reductions in the number of Kiss1 mRNA-expressing neurons and kisspeptin-immunoreactive neurons in the arcuate nucleus (ARC) but not in the anteroventral periventricular nucleus (AVPV) of the PTU-treated rats. Although the serum levels of luteinizing hormone (LH) and estradiol (E2) were unaffected, serum prolactin levels were significantly increased after PTU treatment. These data indicate that kisspeptin expression in the ARC is suppressed under thyroid hormone insufficiency, suggesting that the dysregulation of reproductive function in hypothyroidism is caused by inhibition of kisspeptin neurons in the ARC.

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Estradiol; Estrus; Female; Hypothalamus; Hypothyroidism; Kisspeptins; Luteinizing Hormone; Neurons; Rats

2017
Editorial: molecular endocrinology articles in the spotlight for April 2013.
    Molecular endocrinology (Baltimore, Md.), 2013, Volume: 27, Issue:4

    Topics: Animals; Endocrinology; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Hypothyroidism; Kisspeptins; Leptin; Mice; Periodicals as Topic; Signal Transduction

2013